Disruption of latent inhibition in rats with postnatal hippocampal lesions

Neuropsychopharmacology

Volumn 20, Issue 6, 1999, Pages 525-532

  Grecksch, G ^a   Bernstein, H G ^a   Becker, A ^a   Hollt V ^a   Bogerts, B ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Ibotenic acid; Latent inhibition; Postnatal hippocampal lesion; Rat; Schizophrenia; Shuttle box

Indexed keywords

APOMORPHINE; IBOTENIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONDITIONED REFLEX; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT INHIBITION; LOCOMOTION; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANESTHESIA; ANIMALS; APOMORPHINE; COGNITION DISORDERS; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; HIPPOCAMPUS; IBOTENIC ACID; LEARNING; MOTOR ACTIVITY; NEURAL INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0033151380     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00081-5     Document Type: Article

References (44)

1. Ackil J., Mellgren R.L., Halgren C., Frommer S.P. Effects of CS preexposure on avoidance learning in rats with hippocampal lesions. J Comp Physiol Psychol. 69:1969;739-747.
2. Baruch I., Hemsley D.R., Gray J.A. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Disease. 176:1988;598-606.
3. Bogerts B. The temporolimbic system theory of positive schizophrenic symptoms. Schizophr Bull. 23:1997;423-435.
4. Bolino F., Di Michele V., Di Cicco L., Manna V., Daneluzzo E., Casacchia M. Sensomotor gating and habituation evoked by electro-cutaneous stimulation in schizophrenia. Biol Psychiatry. 36:1994;670-679.
5. Black M.D., Hitchcock J.M., Sorensen S.M. Neonatal hippocampal lesion model of schizophrenia in rats. sex differences and persistence of effects into maturity Society Neurosci. 22:1996;1673.
6. Braff D.L., Stone C., Callaway E., Geyer M.A., Glick D., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
7. Clark A.J., Feldon J., Rawlins J.N. Aspiration lesions of rat ventral hippocampus disinhibit responding in conditioned suppression or extinction, but spare latent inhibition and the partial reinforcement extinction effect. Neurosci. 48:1992;821-829.
8. Dunn L.A., Atwater G.E., Kilts C.D. Effects of antipsychotic drugs on latent inhibition - sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology. 112:1993;315-323.
9. Ellenbroek B.A., Budde S., Cools A.R. Prepulse inhibition and latent inhibition. the role of dopamine in the medial prefrontal cortex Neurosci. 75:1996;535-542.
10. Feldon J., Weiner I. The latent inhibition model of schizophrenic attention disorder. haloperidol and sulpirid enhance rats' ability to ignore irrelevant stimuli Biol Psychiatry. 29:1991;635-646.
11. Flores G., Barbeau D., Quirion R., Srivastava L.K. Decreased binding of dopamine D3 receptors in the limbic subregions following neonatal bilateral lesion of the hippocampus. J Neurosci. 16:1996;2020-2026.
12. Gosselin G., Oberling P., Di Scala G. Antagonism of amphetamine-induced disruption of latent inhibition by the atypical antipsychotic alanzapine in rats. Behav Pharmacol. 7:1996;820-826.
13. Gray J.A., Feldon J., Rawlins J.N.P., Hemsley D.R., Smith A.D. The neuropsychology of schizophrenia. Behav Brain Sci. 14:1991;1-20.
14. Gray N.S., Hemsley D.R., Gray J.A. Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurol Psychiatry Brain Res. 1:1992;83-89.
15. Gray N.S., Pilowsky L.S., Gray J.A., Kerwin R.W. Latent inhibition of drug naive schizophrenics. relationship to duration of illness and dopamine D2 binding using SPET Schizophr Res. 17:1995;95-107. a.
16. Gray J.A., Joseph M.H., Hemsley D.R., Young A.M.J., Warburton E.C., Boulenguez P., Gregoryan G.A., Peters S.L., Rawlins J.N.P., Taib C.T., Yee B.K., Cassady H., Weiner I., Gal G., Gusak O., Joel D., Shadach E., Shalev U., Tarrasch R., Feldon J. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition. Implications for schizophrenia Behav Brain Res. 71:1995;19-31. b.
17. Hemsley D.R. Schizophrenia - A cognitive model and its implications for the psychological intervention. Behav Modification. 20:1996;139-169.
18. Honey R.C., Good M. Selective hippocampal lesions abolish the contextual specificity of latent inhibition and conditioning. Behav Neurosci. 107:1993;23-33.
19. Kaye H., Pearce J.M. Hippocampal lesions attenuate latent inhibition and the decline of orienting response in rats. Q J Exp Psychol. 39B:1987;107-125. a.
20. Kaye H., Pearce J.M. Hippocampal lesions attenuate latent inhibition of a CS and of a neural stimulus. Psychobiol. 15:1987;293-299. b.
21. Killcross A.S., Dickinson A., Robbins T.W. Amphetamine-induced disruptions of latent inhibition are reinforcer mediated - implications for animal models of schizophrenic attentional dysfunction. Psychopharmacology. 115:1994;185-195.
22. Kraepelin E. Dementia praecox and paraphrenia. 1919;Barclay RM, New York.
23. Lipp O.V., Siddle D.A.T., Vaitl D. Latent inhibition in humans. single-cue conditions revisited J Exp Psychol Animal Behav Processes. 18:1992;115-125.
24. Lipska B.K., Weinberger D.R. Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats. Proc Natl Acad Sci USA. 92:1995;8906-8910.
25. Lipska B.K., Weinberger D.R. Hippocampal damage in the neonatal rat as a model of some aspects of schizophrenia. Kato N. The hippocampus. Functions and clinical relevance:1996;465-475 Elsevier, Amsterdam.
26. Lipska B.K., Jaskiw G.E., Weinberger D.R. Postpubertal emergency of hyperresponsiveness to stress and amphetamine after neonatal hippocampal damage. A potential animal model of schizophrenia Neuropsychopharmacology. 9:1993;67-75.
27. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 122:1995;35-43.
28. Lubow R.E. Latent inhibition. Psychol Bull. 79:1973;398-407.
29. Lubow R.E., Gewirtz J.C. Latent inhibition in humans - data, theory and implication for schizophrenia. Psychol Bull. 117:1995;87-108.
30. Lubow R.E., Weiner I., Schlossberg A., Baruch I. Latent inhibition and schizophrenia. Bull Psychonom Soc. 25:1987;464-467.
31. Moran P.M., Fischer T.R., Hitchcock Moser P.C. Effects of clozapine on latent inhibition in the rat. Behav Pharmacol. 5:1996;120-121.
32. Paxinos G, Watson C (1982): The rat brain in stereotaxic coordinates. Sydney New York London, Academic Press.
33. Peters S.L., Joseph M.H. Haloperidol potentiation of latent inhibition in rats. evidence for a critical role at conditioning rather than pre-exposure Behav Pharmacol. 4:1993;183-186.
34. Solomon P.R., Crider A., Winkelmann J.W., Turi A., Kramer R.M., Kaplan L.J. Disruption of latent inhibition in the rat chronic amphetamine or haloperidol-induced supersensitivity. Relationship to schizophrenic attention disorder Biol Psychiatry. 16:1981;519-539.
35. Swerdlow N.R., Braff D.L., Hartston H., Perry W., Geyer M.A. Latent inhibition in schizophrenia. Schizophr Res. 20:1996;91-103.
36. Trimble K.M., Bell R., King D.J. Enhancement of latent inhibition in the rat by the atypical antipsychotic agent remoxipride. Pharmacol Biochem Behav. 56:1997;809-816.
37. Wan R.Q., Giovanni A., Kafka S.H., Corbett R. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine. Behavioral and microdialysis studies Behav Brain Res. 78:1996;211-213.
38. Wan R.Q., Corbett R. Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions. Neuropsychopharmacology. 16:1997;259-268.
39. Weinberger D.R., Lipska B.K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia. a search for common ground Schizophr Res. 16:1995;87-110.
40. Weiner I. Neural substrates of latent inhibition. The switching model Psychol Bull. 108:1990;442-461.
41. Weiner I., Feldon J. The latent inhibition model of schizophrenic attention disorder and antipsychotic drug action. Comment on Dunn, Atwater and Kilts (Psychopharmacology, 1993,112, 315-323) Psychopharmacology. 116:1994;379-380.
42. Weiner I., Lubow R.E., Feldon J. Chronic amphetamine and latent inhibition. Behav Brain Res. 2:1981;285-286.
43. Weiner I., Shadach E., Tarrasch R., Kidron R., Feldon J. The latent inhibition model of schizophrenia. further validation using the atypical neuroleptic clozapine Biol Psychiatry. 40:1996;834-843.
44. Williams J.H., Wellman N.A., Geaney D.P., Feldon J., Cowen P.J., Rawlins J.N.P. Haloperidol enhances latent inhibition in visual tasks in healthy people. Psychopharmacology. 133:1997;262-268.